Metastatic breast cancer in a Nigerian tertiary hospital

African Health Sciences

Volumn 11, Issue 2, 2011, Pages 279-284

  Adisa, A O ^a   Arowolo, O A ^a   Akinkuolie, A A ^a   Titiloye, N A ^a   Alatise, O I ^a   Lawal, O O ^a   Adesunkanmi, A R K ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Breast cancer; Developing country; Metastasis

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MEDICAL RECORD REVIEW; METASTASIS; NIGERIA; PATIENT COMPLIANCE; PLEURA METASTASIS; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DELAYED DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, TEACHING; HUMANS; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, BASAL CELL; NIGERIA; RADIOTHERAPY; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960980039     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P. Survival of metastatic breast carcinoma patients over a 20-year period. Cancer 2005; 104:1742-1750
2. Falkson G, Holcroft C, Gelman R, Tormey D C, Wolter JM, Cummings FJ. Ten-year followup study of premenopausal women with metastatic breast cancer; an Eastern Cooperative Oncology Group study. J Clin Oncol 1995; 13:1453-1458
3. Chung CT, Carlson RW. Goals and objectives in the management of metastatic breast cancer. The Oncologist 2003; 8:514-520
4. Cardoso F, Di Leo A, Lohrisch C, Bernard C, Ferreira F, Piccart MJ. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Annals of Oncology 2002; 13:197-207
5. Bernard-Marty C, Cardoso F, Piccaart MJ. Facts and controversies in systemic treatment of metastatic breast cancer. The Oncologist 2004; 9:617-32
6. Mouridsen HT, Rose C, Brodie AH, Smith IE. Challenges in the endocrine management of breast cancer. Breast. 2003 Aug; 12 Suppl 2:S2-19
7. O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer; phase III trial results. J Clin Oncol 2002;20:2812-2823
8. Mariani G, Petrelli F, Zambetti M, Moliterni A, Fasolo A, Marchiano A, et al. Capecitabine/ Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study. Clin Breast Cancer. 2006;7:321-5
9. Adebamowo CA, Ajayi OO. Breast cancer in Nigeria. West Afr J Med. 2000;19:179-191
10. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000, 321:665-669.
11. Vorobiof DA, Sitas F, Vorobiof G. Breast Cancer Incidence in South Africa. J Clin Oncol, 2001;19(18): 125-127
12. Gilberto Schwartsmann. Breast Cancer in South America: Challenges to Improve Early Detection and Medical Management of a Public Health Problem. J Clin Oncol 19:118-124
13. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-6.
14. Adisa AO, Lawal OO, Adesunkanmi ARK. Paradox of wellness and nonadherence among Nigerian women on breast cancer chemotherapy. Journal of Cancer Research and Therapeutics. 2008 July-Sept; 4(3): 107-110
15. Nour A. Breast-conserving therapy in lowliteracy patients in a developing country. Breast Journal. 2003; 9(2):71-3
16. Ajekigbe AT. Fear of Mastectomy: the most common factor responsible for late presentation of carcinoma of the breast in Nigeria. Clinical Oncology (Royal College of Radiologists.) 1991; 3:78-80.
17. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes and survival in Carolina Breast Cancer Study. JAMA 2006;295:2492-2502
18. Digman JJ. Differences in breast cancer prognosis among African-American and Caucasian Women. CA Cancer J Clin 2000; 50:50-64
19. Okobia MN, Bunker CH. Epidemiological risk factors for breast cancer-a review. Niger J Clin Pract. 2005;8(9):35-42
20. Kaplan HG, Malmgren JA. Impact of triple negative phenotype on breast cancer prognosis. The Breast Journal 2008;14:456-463
21. Ikpatt OF, Ndoma-Egba R. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Cent Afr J Med. 2003;49(11-12):122-6.
22. Gukas ID, Jennings BA, Mandong BM, Igun GO, Girling AC, Manasseh AN, et al. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med. 2005;24(3):209-13.
23. Nalwoga H, Arnes JB, Wabinga H, Akslen LA. Frequency of the basal-like phenotype in African breast cancer. APMIS 2007; 115:1391-9.
24. World Economic Outlook Database- October 2009, International Monetary Fund. Accessed on October 1, 2009
25. World Development Indicators database, World Bank, Data Released on 15 September 2009
26. Adisa AO, Lawal OO, Adesunkanmi ARK. (2008) Evaluation of patients' adherence to chemotherapy for breast cancer. Afr J Health Sci. 2008;15:22-27
27. Juan O, Lluch A, de Paz L, Prosper F, Azagra P, Marugan I, et al. Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED). Breast Cancer Res Treat 1999; 53:105-112
28. Hortobágyi GN. Can we cure limited metastatic breast cancer? J Clin Oncol 2002;20:620-623
29. Diaz-Canton EA, Valero V, Rahman Z, Rodriguez-Monge E, Frye D, Smith T et al. Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texa M.D. Anderson Cancer Center experience and review of the literature. Ann Oncol 1998;9: 413-418